Eastman Kodak Company

Thank you for standing by, and welcome to Eastman Kodak's fourth quarter and four-year 2021 earnings conference call. At this time, all participants are in a listen-only mode. I would now like to hand the call over to Paul Dills.

Thank you, and good afternoon, everyone. I am Paul Dills, Eastman Kodak Company's Chief Tax Officer and Director of Investor Relations. Welcome to Kodak's fourth quarter and full year 2021 earnings call. At 4.15 p.m. this afternoon, Kodak filed its Form 10-K and issued its release on financial results for 2021. You may access the presentation and webcast for today's call on our Investor Center at investor.kodak.com. During today's call, we will be making certain forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. All forward-looking statements are based upon Codex expectations and various assumptions. Future events or results may differ from those anticipated or expressed in the forward-looking statements. Important factors that could cause actual events or results to differ materially from these forward-looking statements include, among others, the risks, uncertainties, and other factors described in more detail in Codex filings with the U.S. Securities and Exchange Commission from time to time. There may be other factors that may cause CODAC's actual results to differ materially from the forward-looking statements. All forward-looking statements attributable to CODAC or persons acting on its behalf only apply as of the date of this presentation and are expressly qualified in their entirety by the cautionary statements included or referenced in this presentation. CODAC undertakes no obligation to update or revise forward-looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of an unanticipated event. In addition, the release just issued and the presentation provided contain certain measures that are deemed non-GAAP measures. Reconciliations to the most directly comparable GAAP measures have been provided with the release and within the presentation on our website in our investor center at investor.kodak.com. Speakers on today's call are Jim Continenza, Kodak's Executive Chairman and Chief Executive Officer, and David Bowenkel, Chief Financial Officer of Kodak. We will not be holding a formal Q&A during today's call. As always, the investor relations team is available for follow-up. I will now turn the call over to Jim.

Welcome, everyone. and thank you for joining the fourth quarter investor call for Kodak. Turning to slide five, I am pleased with our strong full-year performance reflecting continued improvement despite rapid inflationary pressures and resource constraints, including rising costs in raw materials, labor, electricity, natural gas, shipping, and overall supply chain issues. In addition to the pressure surrounding workforce, we have been taking aggressive actions to mitigate the impact of these unprecedented cost increases, including surcharges and variable market pricing. We will continue to take actions to pass along these ongoing increases to our customers. We continue to operate as one codec, focusing on our customer first. We will continue to execute our long-term plan as we navigate the impacts created by the pandemic and the war in Ukraine. Performance highlights for the year includes revenue increase of 121 million or 12% compared to prior year to date period. When excluding the impact of foreign exchange, revenues increased $105 million or 10% compared to the prior year. I'd also like to point out we reduced our net debt by $294 million compared with March of 2019. We remain committed to our continued innovation in digital print. In October, Kodak announced another revolutionary new digital press, the Kodak Ascend Digital Press. This new press earned the prestigious European Digital Press Association 2021 EDP Award in the Industrial Print and Finishing Solutions Best Holding Carton Solution category. Kodak also continued to invest and grow in the Workful software, introducing printing-on-demand access solutions. Turning to slide six, we continue to grow our print business, including Kodak Sonora Process Replace and Kodak Prosper annuities for the year, and overall volumes increased in other business units. Our long-term strategy continues to focus on our core competencies in print, advanced materials, and chemicals. Provide environmentally sustainable solutions, turning the business to focus on innovation, growth, and profitability. As disclosed in our 10-K filing, we are working on new initiatives within the AMC group to leverage our deep expertise in chemistry and strength in layering and coding on multiple substrates, that come from over a century of experience in film manufacturing. These new initiatives are in various stages of commercialization and include EV energy storage battery material manufacturing. We have started coating substrates for EV and energy storage materials. We've started limited production of approximately 3 million square meters with a maximum capacity of 80 million square meters. We will continue to explore opportunities to apply our extensive coating expertise to produce coated substrates in the U.S. I'm pleased to introduce light blocking technology. We plan to leverage our existing proprietary technology to commercialize a carbonless fabric coating branded Codelux. The product is designed to offer superior light management properties and coating compatibility with an unmatched range of fabrics. We are currently completing the installation of a full-scale coating machine to coat fabrics in Eastman Business Park, located in Rochester, New York. Turning to slide seven, we're excited to introduce transparent antennas. We are leveraging our proprietary copper microwire technology and high-resolution printing expertise. It'll allow us to manufacture transparent antennas for the automotive commercial industry and other applications requiring excellent radio frequency and optical performance. I'm excited to introduce reagent manufacturing. As we continue to leverage our trusted brand and expertise in chemicals, we have started the construction of an approximately $20 million facility to manufacture reagents for healthcare applications. As part of the investment, we are currently in the process of building out a clean room manufacturing facility and plan to pursue FDA certification as a CGMP facility. We plan to utilize the new capacity to manufacture limited volumes of testing reagents for the healthcare industry. I will now turn it over to Dave to discuss the 2021 financial results.

Thanks, Jim, and good afternoon. Today, the company filed its form 10K for the year ended December 31, 2021 with the Securities and Exchange Commission. As always, I recommend you read this filing in its entirety. I will share details on the full company results, operational EBITDA, and cash flow for 2021. On slide 8, as we reported in our earnings release, for 2021, we reported revenues of $1.15 billion compared to $1.029 billion in the prior year, for an improvement of $121 million. Adjusting for the favorable impact of foreign exchange of $16 million, revenue increased by $105 million compared to the prior year. On a U.S. GAAP basis, we reported net income for 2021 of $24 million compared to net loss of $541 million in 2020. The 2021 results include income of $7 million related to changes in fair value of embedded derivative liability features, $4 million related to non-cash changes in employee benefit reserves, $7 million related to legal settlements, and expense of $1 million related to net loss on the sale of assets. The 2020 results include expense of $382 million related to changes in fair value for the embedded derivative liabilities, $4 million related to non-cash changes in employee benefit reserves, $2 million related to the loss and extinguishment of debt, $3 million related to a trade name impairment, $3 million related to an increase in accounts receivable reserves, $10 million related to a net gain on the sale of assets, and the $167 million non-cash expense as a result of the increase in deferred tax valuation allowances outside the U.S. Excluding the impact of these current and prior year items, the 2021 adjusted net income was $7 million compared to adjusted net income of $10 million in the prior year. Operational EBITDA for 2021 was $11 million compared to a negative $1 million in 2020. Excluding the unfavorable impact of foreign exchange in the current year and an increase in accounts receivable reserves in the prior year and adjusting for the impact of changes in employee benefit reserves, operational EBITDA increased by $2 million from the prior year. Operational EBITDA for 2021 was favorably impacted by improvement in revenue and manufacturing costs from increases in volume, partially offset by ongoing global cost increases in 2021. The current year operational EBITDA results did not benefit from $25 million in savings from temporary pay reductions and furloughs that largely ended in January 2021. Since these reductions were reinstated beginning in January 2021, the level of improvement year-over-year in operational EBITDA is much more significant than what is reported. We are proud of the improvements we have created IN 2021. ON A FULL YEAR BASIS, VOLUMES FOR SONORA PROCESSORY PLATES IMPROVED BY 31% AND THE ANNUITY REVENUE FOR PROSPER IMPROVED BY 21%. WE ALSO CONTINUED TO INVEST IN FUTURE GROWTH AREAS OF ULTRA STREAM AND ADVANCED MATERIALS. OUR BALANCE SHEET IMPROVED DURING 2021 AS WELL. JIM INDICATED THAT OUR NET DEBT IMPROVED BY $294 MILLION SINCE MARCH OF 2019. That is largely due to the series of financial transactions the company announced in March of 2021, which provide access to new capital, address maturing obligations, and strengthen the company's ability to invest in strategic growth initiatives in our core businesses. Summarizing those financial transactions, Kodak entered into a term loan for $225 million with a commitment to provide delayed draw term loans of up to an additional $50 million, which may be drawn on or before February 26, 2023. We also redeemed $100 million in Series A preferred stock, issued $100 million in Series B preferred stock in exchange for $100 million of Series A preferred stock, and issued $100 million in Series C preferred stock. The company also issued $25 million in unsecured convertible notes and raised $10 million from the sale of common stock to the same debt holder. We also amended and extended our ABL at the same time. These transactions together provided the company with $233 million of incremental cash in the year after fees, expenses, and incremental letter of credit facility funding and provided the company with $50 million of incremental liquidity through the delayed draw. Jim mentioned several initiatives which the company is investing in to provide future growth. The balance sheet improvement which occurred during 2021 provides the platform for these investments. Moving on to the company cash performance presented on slide 9. The company ended 2021 with $362 million in cash and cash equivalents, an increase of $166 million from December 31, 2020. As presented on the bottom portion of the slide, excluding net proceeds from refinancing transactions, funding of the letter of credit facility, proceeds from stock option exercises, project and consulting payments, and the impact of foreign exchange, as well as adjusting for the $25 million in furloughs and pay reductions mentioned above, the year-over-year improvement in cash and cash equivalents was approximately $46 million. This improvement is significant and occurred despite the increase in costs, which we continue to manage. As an example, aluminum costs increased by approximately $80 million on an annual basis throughout 2021, but were more than offset by the numerous measures that have been implemented to mitigate these costs by our team. In fact, as we move into 2022, the London Metal Exchange aluminum price continues to trade at a level well above historical prices. As of March 9, 2022, the LME Euro price was approximately 2,700 compared to the price as of January 1, 2020, of approximately 1,600, but has been as high as approximately 3,200 within that period. In addition, other input costs like labor, shipping, chemicals and other raw materials, electricity, and natural gas have risen significantly. The war in Ukraine further exacerbates these challenges and also impacts the price and continuity of supply as well as availability. To mitigate these impacts, we will continue to execute on our plan through surcharges, price actions, and factory and distribution efficiencies. as we strive to maintain continuity of supply for our customers. During 2021, cash used in operating activities was $47 million, driven primarily by cash use from net earnings of $32 million and cash used from balance sheet changes of $15 million, including a change in working capital of $14 million and a decrease in other liabilities of $29 million. Accounts payable increased by $38 million, INVENTORY INCREASED BY $19 MILLION AND ACCOUNTS RECEIVABLE INCREASED BY $5 MILLION. CASH USED IN INVESTING ACTIVITIES WAS $20 MILLION DURING 2021 AS COMPARED TO CASH USAGE OF $13 MILLION IN THE PRIOR YEAR. CASH PROVIDED BY FINANCING ACTIVITIES WAS $238 MILLION FOR 2021 COMPARED TO $10 MILLION IN THE PRIOR YEAR. CASH PROVIDED BY FINANCING ACTIVITIES INCLUDED $247 MILLION OF INCREMENTAL CASH AFTER FEES AND EXPENSES DRIVEN BY THE FINANCIAL TRANSACTIONS ANNOUNCED ON MARCH 1ST, WHICH I REFERRED TO EARLIER. RESTRICTED CASH AT THE END OF THE YEAR WAS $61 MILLION, AN INCREASE OF $1 MILLION FROM DECEMBER 31, 2020. RESTRICTED CASH PRIMARILY REPRESENTS CASH COLLATERAL REQUIRED UNDER THE NEW LETTER OF CREDIT FACILITY IN ADDITION TO ESCROS TO SECURE VARIOUS ONGOING OBLIGATIONS. The refinancing transactions created the need to increase restricted cash by $14 million in Q1 of 2021. Subsequent to that point, our team has reduced restrictions on cash by $15 million during the year, which reflects significant effort and a more efficient balance sheet. We will continue to focus on removing restrictions on cash to create liquidity for the company. Finally, as disclosed in our Form 10-K, We remain in compliance with all applicable financial covenants. I will now turn the discussion back to Jim.

Thank you, Dave. In summary, in 2021, we continued to navigate through an unusual, challenging business environment and delivered revenue growth in all segments for the first time in years. We also saw increase in customer satisfaction and market share in our key print businesses, achievements which reflect the success of our ongoing strategy. We continue to focus on our core businesses in commercial print, advanced materials, and chemicals. Invest in product innovations and put our customers first in everything we do. Thank you for attending the call and your continued interest in Eastman Kodak.

Ladies and gentlemen, this concludes today's conference call. Thank you for participating. You may now disconnect.